Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
J Exp Med (1996) 184 (5): 2037–2041.
Currently there are no citedby results. Try again later.
